Not applicableWithdrawnNCT05307627What this trial is testingThe Effects of Low Dose Naltrexone (LDN) on Diseases of AgingWho this might be right forAging AgelessRx
Testing effectiveness (Phase 2)Looking for participantsNCT06366724What this trial is testingLIFT: Life Improvement TrialWho this might be right forME/CFSLong COVIDPASC Brigham and Women's Hospital 160
Large-scale testing (Phase 3)Study completedNCT04502251What this trial is testingLDN and tDCS in FibromyalgiaWho this might be right forFibromyalgia Centro Universitario La Salle 92
Not applicableWithdrawnNCT03762798What this trial is testingCan The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to NaltrexoneWho this might be right forSubstance Use DisordersSubstance AbuseSubstance Use+1 more The Cleveland Clinic
Testing effectiveness (Phase 2)Study completedNCT04409041What this trial is testingOral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing AlopeciaWho this might be right forLichen PlanopilarisFrontal Fibrosing Alopecia Washington University School of Medicine 43
Large-scale testing (Phase 3)Study completedNCT00501696What this trial is testingPlacebo-Controlled, Crossover-Design Study of the Effects of Low Dose NaltrexoneWho this might be right forMultiple Sclerosis University of California, San Francisco 80
Testing effectiveness (Phase 2)Study completedNCT05430152What this trial is testingLow-dose Naltrexone for Post-COVID Fatigue SyndromeWho this might be right forPost-Viral Fatigue Syndrome Luis Nacul 160
Testing effectiveness (Phase 2)Looking for participantsNCT04678895What this trial is testingLow-Dose Naltrexone for the Treatment of Painful Diabetic NeuropathyWho this might be right forPainful Diabetic Neuropathy Dartmouth-Hitchcock Medical Center 35
Not applicableStudy completedNCT00568555What this trial is testingEffects of Low Dose Naltrexone in FibromyalgiaWho this might be right forFibromyalgiaPersian Gulf Syndrome Stanford University 53
Post-approval studies (Phase 4)Study completedNCT02806440What this trial is testingLow Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?Who this might be right forFibromyalgia Rigshospitalet, Denmark 58
Testing effectiveness (Phase 2)Study completedNCT00135759What this trial is testingAddition of Naltrexone to Methadone TaperWho this might be right forHeroin DependenceOpioid-Related DisordersSubstance-Related Disorders National Institute on Drug Abuse (NIDA) 174
Testing effectiveness (Phase 2)Study completedNCT03008590What this trial is testingLow Dose Naltrexone for Chronic Pain From ArthritisWho this might be right forOsteoarthritisArthritis, RheumatoidArthritis, Psoriatic VA Office of Research and Development 29
Testing effectiveness (Phase 2)Ended earlyNCT04450316What this trial is testingLow-dose Naltrexone for Bladder Pain SyndromeWho this might be right forBladder Pain SyndromeInterstitial Cystitis Stanford University 29
Testing effectiveness (Phase 2)Study completedNCT04052139What this trial is testingSt. PETERsburg Pain and Alcohol Intervention With Naltrexone and GabapentinWho this might be right forChronic PainAlcohol Use, UnspecifiedHIV Infections Boston Medical Center 45
Not applicableLooking for participantsNCT02502162What this trial is testingLow-Dose Naltrexone for the Treatment of Complex Regional Pain SyndromeWho this might be right forComplex Regional Pain Syndrome Stanford University 120
Testing effectiveness (Phase 2)Study completedNCT03194555What this trial is testingThe Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen CombinationWho this might be right forMigraine With or Without Aura Allodynic Therapeutics, Inc 12
Testing effectiveness (Phase 2)Study completedNCT01690546What this trial is testingLow Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid DependenceWho this might be right forOpiate Dependence Paolo Mannelli 38
Testing effectiveness (Phase 2)Study completedNCT04604704What this trial is testingPilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 SyndromeWho this might be right forCovid19Long COVID-19Post-COVID-19 Syndrome AgelessRx 36
Testing effectiveness (Phase 2)Ended earlyNCT01650350What this trial is testingLow Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal CancerWho this might be right forMelanomaProstate CancerRenal Cancer Brown University 7
Testing effectiveness (Phase 2)Study completedNCT01174914What this trial is testingEffectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+Who this might be right forHIV Seropositivity The Ojai Foundation 171